These data demonstrated that miR-635 was downregulated in the human bone marrow of CML patients with Imatinib resistance and CML IR cell lines, implying that miR-635 might be an imperative factor for mediating the PXN-AS1/miR-635/GS axis. This evidence concerns the gene PXN and chronic myelogenous leukemia, BCR-ABL1 positive.